Manufactured by Nicos Labs Pvt. Ltd., our Nicotine
EP/USP is produced under stringent quality controls to meet the demanding
requirements of pharmaceutical, nicotine replacement therapy (NRT), research,
and formulation industries worldwide.
Every batch undergoes comprehensive quality testing to ensure exceptional
purity, consistency, and compliance with international pharmacopeial standards.
| Parameter | Specification |
|---|---|
| Product Name | Nicotine EP / USP |
| Purity | Up to 99.97% |
| Appearance | Clear Transparent Liquid |
| Odor | Characteristic |
| Shelf Life | 24 Months |
| Packaging | Pharmaceutical Grade Containers |
| Storage | Cool, Dry, Protected from Light |
Production of nicotine-containing pharmaceutical
formulations requiring high purity and regulatory compliance.
Nicotine Replacement Therapy (NRT)
Suitable for manufacturing:
Research & Analytical Use
High-purity nicotine for laboratory, analytical, and product development
applications.
We offer flexible packaging solutions for domestic and international customers:
Available pack sizes from laboratory quantities to industrial bulk volumes.
Nicos Labs Pvt. Ltd. manufactures high-quality Nicotine
Polacrilex USP/EP, a nicotine–ion exchange resin complex specifically developed for
controlled nicotine release applications. Designed for pharmaceutical manufacturers,
this product delivers exceptional consistency, uniform nicotine loading, and
reproducible release characteristics required for modern nicotine replacement
therapies and oral delivery systems.
Our Nicotine Polacrilex is manufactured under controlled conditions and tested to
ensure reliable performance, stability, and batch-to-batch consistency.
| Parameter | Specification |
|---|---|
| Product Name | Nicotine Polacrilex USP / EP |
| Description | Nicotine-Ion Exchange Resin Complex |
| Grade | Pharmaceutical Grade |
| Appearance | Off-White to Cream Colored Powder |
| Nicotine Loading | As per Pharmacopoeial Specification |
| Particle Size | Controlled Distribution |
| Shelf Life | 24 Months |
| Packaging | Pharmaceutical Grade Packaging |
Widely used in the manufacture of nicotine replacement products requiring controlled nicotine release:
Available in pharmaceutical-grade packaging formats:
Available pack sizes from laboratory quantities to industrial bulk volumes.
Nicos Labs Pvt. Ltd. manufactures high-quality Nicotine
Bitartrate Dihydrate USP/EP, a stable crystalline nicotine salt designed for
pharmaceutical, analytical, and formulation development applications. Compared to
freebase nicotine, Nicotine Bitartrate Dihydrate offers enhanced stability, reduced
volatility, improved handling characteristics, and greater formulation flexibility.
Produced under stringent quality standards, our Nicotine Bitartrate Dihydrate
delivers consistent quality, defined stoichiometry, and reliable performance
required by pharmaceutical manufacturers, research institutions, and formulation
scientists.
| Parameter | Specification |
|---|---|
| Product Name | Nicotine Bitartrate Dihydrate USP / EP |
| Grade | Pharmaceutical Grade |
| Appearance | White to Off-White Crystalline Powder |
| Assay | As per USP / EP Specification |
| Water Content | Controlled |
| Residual Solvents | Controlled |
| Standards | USP / EP |
| Shelf Life | 24 Months |
| Storage | Cool, Dry, Well-Sealed Containers |
Enhanced Stability : The salt form offers
superior chemical stability compared to freebase nicotine, helping maintain
product quality during storage and formulation.
Reduced Volatility : Lower volatility minimizes handling losses and
improves manufacturing consistency.
Excellent Processing Characteristics : The crystalline powder form
provides improved weighing accuracy, handling convenience, and formulation
reproducibility.
Consistent Composition : Manufactured under controlled conditions to
ensure reliable assay values and defined stoichiometric composition.
Regulatory Support :
Supplied with comprehensive documentation including:
Pharmaceutical Research & Development :
Suitable for formulation development, process optimization, and product
innovation projects.
Nicotine Salt Formulation Studies : Ideal for evaluating nicotine
salt systems requiring enhanced stability and controlled performance.
Oral Nicotine Delivery Systems : Used in the development of oral
nicotine formulations and non-combustible nicotine products.
Analytical & Reference Standards : Suitable for analytical method
development, validation studies, and laboratory applications.
Stability & Compatibility Studies : Widely used for pharmaceutical
compatibility assessments and accelerated stability programs.
Academic & Industrial Research : Preferred by universities, contract
research organizations, and industrial R&D laboratories.
Pilot-Scale Process Development : Supports scale-up activities and
commercial formulation development.
Available in pharmaceutical-grade packaging formats :
Nicos Labs Pvt. Ltd. manufactures a comprehensive range of
high-purity nicotine salts designed for pharmaceutical development, nicotine
delivery systems, and specialized formulation requirements.
By combining premium-grade nicotine with carefully selected pharmaceutical-grade
acids, we produce nicotine salts that offer enhanced stability, improved handling
characteristics, and consistent performance across a wide range of applications.
Our manufacturing capabilities allow customers to select from standard nicotine
salts or develop customized nicotine salt systems tailored to specific product
requirements.
Customized nicotine salt combinations can be developed based on customer specifications and formulation requirements.
Nicos Labs can develop nicotine salts according to customer-specific requirements, including:
Available in pharmaceutical-grade packaging formats:
Welcome to Nicos Labs, your premier provider of standardized herbal extract and phytochemicals. Founded with a vision to revolutionize the industry, we are dedicated to crafting products that prioritize quality, purity, and innovation.
